Healthcare is transforming at a frenzied pace. The journey from a volume-based laboratory to one focused on high-value patient outcomes requires leveraging technology and data analytics, collaborating with key stakeholders, integration across the enterprise, and heightened engagement...
The paradigm of American health care is shifting from volume-based payment systems to value-based payment – based on better patient outcomes and cost-effective delivery of healthcare. Several leading health systems are moving to leverage the massive real-time data emanating from their in-system...
This presentation draws from more than 40 years of laboratory management experience and provides specific examples of exploiting opportunities and overcoming threats in order to communicate the value of the laboratory.
Across the US, many community-based laboratories are experiencing erosion of their outreach program volumes and revenue. This erosion is largely due to the lack of access to insurance contracts and/or aggressive steerage campaigns launched by insurance companies.
Col. Brian Castelton, US Air Force, Col. Kris Calero, US Army and CDR Adrian Gaskin, US Navy, will provide an overview of laboratory medicine within the Military Health System (MHS) and Department of Defense (DoD). Panel members will share their experiences, challenges and solutions for laboratory..
Brigadier General Dienst will reviews current strategies and initiatives of the DHA as it pertains to implementing shared services with common measurement of outcomes; enabling rapid adoption of proven practices, helping reduce unwanted variation, improving the coordination of care across time and t
This breakout will offer some best practices in creating a leadership environment that appreciates and capitalizes on different personalities that can be brought together to form a successful and functional work team.
Rodney and James discuss the proposed FDA regulation of Laboratory Developed Tests (LDTs) and how these changes will impact your laboratory operations. Even if you don’t use LDTs, your reference labs might, so you could still be affected.
On June 17, 2016 CMS published the Final Rule for implementing the Protecting Access to Medicare Act (PAMA) creating a new model for establishing the Medicare Clinical Laboratory Fee Schedule (CLFS) and substantially reducing payments. The PAMA rule marks the first real changes in how the CLFS...
On June 17, 2016 CMS published the Final Rule for implementing the Protecting Access to Medicare Act (PAMA) creating a new model for establishing the Medicare Clinical Laboratory Fee Schedule (CLFS) and substantially reducing payments.